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ABSTRACT 
A range of surface, secreted and somatic antigens from filarial parasites have been studies in order 
to analyse the response of human infected with these pathogens, and to develop reliable diagnostic and 
prophylactic agents. Diagnostic procedures, which are urgently required for targetting chemotherapy, are 
being developed by two techniques. Firstly, detection of host antibody is carried out using selected, 
specific parasite antigens in the form of recombinant peptides from a filarial DNA library. Secondly, 
measurement of parasite by a monoclonal antibody "antigen-capture" assay. In addition, a longer-term 
objective of our collaborative study is to isolate molecules which may stimulate the immune system to 
mount a protective immune response against filarial parasites. A major focus ha? been a parasite surface 
glycoprotein known to be closely conserved between adult worms of Brugia malayi, B. timon and 
Wuchereria bancrofti. This antigen has been cloned from a cDNA library, and its primary sequence 
established; in addition to being a constant feature of the adult surface, it is expressed by developing 
larvae and represents an attractive target for vaccine production. Finally, one of the most intriguing 
questions in filariasis relates to the genesis of pathological reactions. Although this is a difficult problem, 
we are now beginning to compare the immune responses of individuals of differing clinical status to 
certain defined parasite antigens, in an attempt to correlate disease development with particular categories 
of immune response in infected patients. In this way there is hope to advance the basic understanding of 
filarial disease, while providing practical means for controlling filariasis at the individual and community 
levels. 
QUESTIONS AND ANSWERS : 
1. Question: What do you think about chyluria patients ? 
Can we use your technique (two site ELISA) to differentiate filarial patients from non 
filarial patients by utilizing their urine ? 
Answer : The two site ELISA should be tested in these patients. Other investigators have reported 
circulating antigen in urine of filarial patients, and levels of antigen in urine may be higher 
in individuals with lesions causing chyluria. 
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2. Question: As P.C. is produced by other nematodes how would this be excluded when the test is used 
in areas where other nematodes than filarids also exists ? 
Answer : This is the most critical question, but surprisingly few problems have arisen in our and 
others' studies measuring PC antigens. However, for this reason I am suggesting that the 
PC test should not be used as the sole diagnostic criterion. 
3. Question: 1. Dealing with the immunological diagnosis, what kind of relationship did you observe in 
respect to the disease stage ? Didn't it influence the detection of circulating Ag ? 
2. What is the current status of the role of cell mediated immunity ? 
3. What is the significance of the recombinant antigen which were recognized only by Mf 
negative? 
Answer : 1. All microfilaremic cases were strongly antigen positive, but not all individuals with 
filarial symptoms but without microfilariae showed circulating antigen. Presumably 
these were cases where the infection had gone but lesions persisted. In addition some 
asymptomatic, amicrofilaraemic "endemic normals" were antigen-positive, presumably 
reflecting an occult infection. 
2. We are only just beginning to examine the T cell populations in filariasis. Perhaps the 
greatest advance in this area has been reported by Dr.T. Nutruan of the NIH, USA : he 
foundT cells from microfilaraemics were specifically less responsive to parasite antigens 
compared to T cells from endemic normals. 
3. If an antigen were consistently recognized by amicrofilaraemics but not by 
microfilaraemics, it may be implicated in antibody-dependent clearance of microfilariae. 
However, we found that individuals varied significantly in all anti-peptide responses so 
that no single correlation between antigen recognition and carrier status emerged. 
4. Question: In view of the presence of considerable crossreactivity in filariasis sera, how much of this 
response could be due to polyclonal immune response(s) (eg.antibody) and how could such 
"upscale" regulation of the immune response impact on sorting out the "bestVpep- 
tideslepitopes for serology. 
Answer : These does not appear to be nonspecific, polyclonal immune activation in filariasis, and in 
fact microfilaraemic individuals often show very low antibody responses. Otherwise, a 
generalised stimulation would certainly obscure any analysis of responses to single peptide 
epitopes. 
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